CNR Institutional Research Information System

FUSARO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.062
NA - Nord America 1.028
EU - Europa 591
SA - Sud America 348
AF - Africa 25
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 967
SG - Singapore 881
CN - Cina 426
BR - Brasile 271
VN - Vietnam 223
HK - Hong Kong 195
IT - Italia 189
FR - Francia 114
NL - Olanda 113
JP - Giappone 78
BD - Bangladesh 71
KR - Corea 69
FI - Finlandia 58
IN - India 32
DE - Germania 31
CA - Canada 29
AR - Argentina 24
EC - Ecuador 20
GB - Regno Unito 20
MX - Messico 12
ID - Indonesia 10
IL - Israele 10
PL - Polonia 9
UY - Uruguay 9
VE - Venezuela 9
TR - Turchia 8
UA - Ucraina 7
CR - Costa Rica 6
DZ - Algeria 6
IQ - Iraq 6
CL - Cile 5
CO - Colombia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AM - Armenia 4
CH - Svizzera 4
ES - Italia 4
GR - Grecia 4
KE - Kenya 4
RU - Federazione Russa 4
ZA - Sudafrica 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
LV - Lettonia 3
NP - Nepal 3
SE - Svezia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
GT - Guatemala 2
HN - Honduras 2
IE - Irlanda 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MV - Maldive 1
MZ - Mozambico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 4.055
Salva come PNG Salva come JPEG
Città #
Singapore 532
Santa Clara 276
Hong Kong 192
Hefei 168
Beijing 103
San Jose 103
Lauterbourg 98
Ashburn 85
Ho Chi Minh City 74
Seoul 67
Tokyo 67
Hanoi 60
Los Angeles 41
Council Bluffs 38
Dallas 36
Lappeenranta 30
New York 28
Helsinki 26
São Paulo 20
Buffalo 17
Rome 16
Haiphong 14
Orem 13
Atlanta 9
Guayaquil 9
Milan 9
Minamishinagawa 9
Montevideo 9
Warsaw 9
Belo Horizonte 8
Chennai 8
Florence 8
Munich 8
Rio de Janeiro 8
Toronto 8
Bengaluru 7
Brasília 7
Can Tho 7
Nuremberg 7
Phoenix 7
Amsterdam 6
Chicago 6
Quito 6
Thái Bình 6
Bari 5
Fortaleza 5
Frankfurt am Main 5
London 5
San José 5
Tashkent 5
Athens 4
Bắc Giang 4
Cascina 4
Da Nang 4
Elk Grove Village 4
Miami 4
Montreal 4
Nairobi 4
Naples 4
Palermo 4
Santiago 4
Volta Redonda 4
Amman 3
Baghdad 3
Brescia 3
Brooklyn 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Carapicuíba 3
Catania 3
Colombo 3
Contagem 3
Detroit 3
Falkenstein 3
Gustavo Adolfo Madero 3
Hangzhou 3
Hyderabad 3
Madrid 3
Manaus 3
New Delhi 3
Ninh Bình 3
Paris 3
Porto Alegre 3
Ribeirão Preto 3
Riga 3
San Francisco 3
Stockholm 3
São Gonçalo 3
São José dos Campos 3
Tbilisi 3
Teófilo Otoni 3
Thái Nguyên 3
Turin 3
Yerevan 3
Zurich 3
Algiers 2
Batna City 2
Biên Hòa 2
Boardman 2
Totale 2.453
Salva come PNG Salva come JPEG
Nome #
Bone Mineral Density Predicts Fractures in Chronic Kidney Disease 97
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method 94
Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives 89
[Biomarkers and Bone Turnover Markers in Chronic Kidney Disease - Mineral and Bone Disorders (CKD-MBD): Recent Advances] 76
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis 72
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients 71
Vitamin K2 is a key regulator of clinically relevant molecular processes 70
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease 69
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 67
Vitamin K in CKD Bone Disorders 60
The Role of Vitamin K in CKD-MBD 58
Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines 57
SEVELAMER USE IS ASSOCIATED WITH DECREASED VITAMIN K LEVELS IN HEMODIALYSIS PATIENTS: RESULTS FROM VITAMIN K ITALIAN (VIKI) STUDY. 56
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options 54
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve 53
Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study 52
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? 51
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism 51
Romosozumab Use and Cardiovascular Events 51
Simple Statistical Measures for Assessing the Accuracy of a Diagnostic Test in Clinical Medicine 51
Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake 50
A Novel Quantitative Computer-Assisted Score Can Improve Repeatability in the Estimate of Vascular Calcifications at the Abdominal Aorta 49
Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population 48
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease 48
Sex-related differences in vitamin D testing in the Veneto Region, Italy: a retrospective analysis from 2005 to 2016 48
The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study 47
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 46
Ten tips on how to assess bone health in patients with chronic kidney disease 45
New Insight into the Role of Vitamin D in the Stroke Risk: A Meta-Analysis of Stratified Data by 25(OH)D Levels 43
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter 43
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action 43
Vitamin K plasma levels determination in human health 42
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study 42
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes 42
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices 41
Vitamin D assay and supplementation: still debatable issues 41
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 41
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes 41
Comprehensive Associations between Acidosis and the Skeleton in Patients with Kidney Disease 40
Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon? 40
Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs 39
Phosphate and bone fracture risk in chronic kidney disease patients 39
Changes in Bone Quality after Treatment with Etelcalcetide 39
Clinical relevance and future perspective of fractures in patients with chronic kidney disease 37
Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study 37
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 37
Vitamin K and kidney transplantation 36
Evaluating benefit from vitamin D supplementation: defining the area for treatment 36
Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet 35
Vitamin K and bone 35
Vitamin K and osteoporosis 35
High-resolution peripheral quantitative computed tomography: research or clinical practice? 34
Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients 34
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor 33
Fragility fracture in the Chronic Kidney Disease (CKD) 33
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data 32
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients 32
A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update 32
Percorso diagnostico-terapeutico per il paziente con calcolosi renale: update 2020 31
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data 31
Low vitamin K1 intake in haemodialysis patients 31
HO-1 Attenuates Hypertension-Induced Inflammation/Oxidative Stress: Support From Bartter's/Gitelman's Patients 31
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients 31
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 31
Vitamin K effects in human health: new insights beyond bone and cardiovascular health 31
CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DISEASE 30
Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship 30
SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: Implications for hypertension 29
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs 29
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy 29
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1–3 29
Vitamin K effects in human health: new insights beyond bone and cardiovascular health (vol 33, pg 239, 2020) 28
Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation 28
A new CHA2DS2VASC score integrated with eGFR, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease. 28
Effect of olmesartan on oxidative stress in hypertensive patients. Mechanistic support to clinical trials derived evidence 28
Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report 27
Adverse effects of proton pump inhibitors in chronic kidney disease 27
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3 26
High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications 26
Fractures in chronic kidney disease: neglected, common, and associated with sickness and death 26
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective 26
Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid covid-19 patients: A hypothesis-generating study 26
CIGARETTE SMOKING IS ASSOCIATED WITH DECREASED BGP LEVELS IN HEMODIALYSIS PATIENTS 26
WARFARIN USE IS ASSOCIATED WITH HIGHER PREVALENCE VERTEBRAL FRACTURES, VASCULAR CALCIFICATIONS AND INCREASED MORTALITY IN CHRONIC KIDNEY DISEASE 25
EVALUATION OF VITAMIN D STATUS DURING KIDNEY TRANSPLANTATION: FACTORS RELATED AND EFFECT OF THE TREATMENT 25
Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder 25
The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures 25
DECREASED OSTEOCALCIN LEVELS AND INCREASED MORTALITY IN HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS 24
VITAMIN K DEPENDENT PROTEINS AFTER KIDNEY TRANSPLANTATION: RESULTS FROM PROSPECTIVE STUDY. 24
Utility of Cardiac Biomarkers in the Setting of Kidney Disease 24
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 24
Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis 24
THE RELATIONSHIP BETWEEN THE SPINE DEFORMITY INDEX BIOCHEMICAL PARAMETERS OF BONE METABOLISM AND VASCULAR CALCIFICATIONS: RESULTS FROM THE EPIDEMIOLOGICAL VERTEBRAL FRACTURES ITALIAN STUDY IN DIALYSIS PATIENTS (EVERFRACT STUDY) 23
Vitamin K and bone metabolism in the elderly with normal and reduced kidney function 23
The Role of Vitamin K in Vascular Calcification 23
Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease 23
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 22
How and when to assess bone mineral density and bone quality in chronic kidney disease patients 22
BONE DISEASE THERAPY IN CKD CAN INFLUENCE LEVELS VITAMIN K DEPENDENT PROTEINS (VIKI STUDY) 22
Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies 22
Totale 3.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.378
article - articoli 14.618
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 219
Totale 31.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 0 3 5 1
2024/20251.671 2 6 98 85 443 45 76 74 47 132 376 287
2025/20262.478 123 215 248 347 402 52 347 138 174 174 112 146
2026/202796 96 0 0 0 0 0 0 0 0 0 0 0
Totale 4.254